Colangelo Dominick — SEC Form 4 filings
SEC reporting owner CIK 1313403. 26 Form 4 filings on record with FilingPulse; latest filed 2026-06-04.
Transaction summary — filings shown
Covers all 26 filings on record, filed 2024-01-19 to 2026-06-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 28 legs across 14 filings — 514,460 shares, $23,300,542 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 104.
- Largest priced transaction: sale of 26,591 shares @ $46.31 ($1,231,429) in Vericel Corp, filed 2025-03-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Vericel Corp (VCEL) | President and CEO, Director | 23 | — | 28 legs · 514,460 sh · $23,300,542 | 101 |
| Trevi Therapeutics, Inc. (TRVI) | Director | 3 | — | — | 3 |
Form 4 filings — Colangelo Dominick
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-04 | 4 | Trevi Therapeutics, Inc. (TRVI) | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2026-02-26 | 4 | Vericel Corp (VCEL) | Option exercise (M): 18,250 · Option exercise (M): 18,250 @ $0 · Tax withholding (F): 8,824 @ $38.09 · Option exercise (M): 18,250 (derivative) · Option exercise (M): 18,250 (derivative) | EDGAR |
| 2026-02-20 | 4 | Vericel Corp (VCEL) | Option exercise (M): 18,250 · Option exercise (M): 11,700 @ $0 · Tax withholding (F): 5,657 @ $37.41 · Option exercise (M): 18,250 (derivative) · Option exercise (M): 11,700 (derivative) · Grant/award (A): 182,500 (derivative) @ $0 · +1 more | EDGAR |
| 2025-06-13 | 4 | Trevi Therapeutics, Inc. (TRVI) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | Vericel Corp (VCEL) | Option exercise (M): 14,062 @ $2.65 · Sale (S): 14,062 @ $42.25 · Option exercise (M): 14,063 @ $2.65 · Sale (S): 14,063 @ $41.53 · Option exercise (M): 14,062 (derivative) @ $0 · Option exercise (M): 14,063 (derivative) @ $0 | EDGAR |
| 2025-04-11 | 4 | Vericel Corp (VCEL) | Option exercise (M): 24,850 @ $2.75 · Sale (S): 24,850 @ $41.11 · Option exercise (M): 24,850 @ $2.75 · Sale (S): 24,850 @ $41.89 · Option exercise (M): 24,850 (derivative) @ $0 · Option exercise (M): 24,850 (derivative) @ $0 | EDGAR |
| 2025-03-14 | 4 | Vericel Corp (VCEL) | Option exercise (M): 26,591 @ $1.95 · Sale (S): 26,591 @ $46.31 · Option exercise (M): 26,592 @ $1.95 · Sale (S): 26,592 @ $45.78 · Option exercise (M): 26,591 (derivative) @ $0 · Option exercise (M): 26,592 (derivative) @ $0 | EDGAR |
| 2025-02-26 | 4 | Vericel Corp (VCEL) | Option exercise (M): 18,250 @ $0 · Tax withholding (F): 8,459 @ $52.33 · Option exercise (M): 18,250 (derivative) | EDGAR |
| 2025-02-24 | 4 | Vericel Corp (VCEL) | Grant/award (A): 182,500 (derivative) @ $0 · Grant/award (A): 73,000 (derivative) @ $0 | EDGAR |
| 2025-02-20 | 4 | Vericel Corp (VCEL) | Option exercise (M): 18,250 · Option exercise (M): 11,700 @ $0 · Tax withholding (F): 5,423 @ $57.28 · Option exercise (M): 8,938 @ $0 · Tax withholding (F): 4,196 @ $57.78 · Option exercise (M): 18,250 (derivative) · +2 more | EDGAR |
| 2024-11-15 | 4 | Vericel Corp (VCEL) | Option exercise (M): 17,500 @ $3.02 · Sale (S): 17,500 @ $55.57 · Option exercise (M): 17,500 @ $3.02 · Sale (S): 17,500 @ $53.93 · Option exercise (M): 17,500 (derivative) @ $0 · Option exercise (M): 17,500 (derivative) @ $0 | EDGAR |
| 2024-10-18 | 4 | Vericel Corp (VCEL) | Option exercise (M): 17,500 @ $3.02 · Sale (S): 17,500 @ $41.38 · Option exercise (M): 17,500 @ $3.02 · Sale (S): 17,500 @ $40.34 · Option exercise (M): 17,500 (derivative) @ $0 · Option exercise (M): 17,500 (derivative) @ $0 | EDGAR |
| 2024-09-13 | 4 | Vericel Corp (VCEL) | Option exercise (M): 17,500 @ $3.02 · Sale (S): 17,500 @ $43.37 · Option exercise (M): 17,500 @ $3.02 · Sale (S): 17,500 @ $43.90 · Option exercise (M): 17,500 (derivative) @ $0 · Option exercise (M): 17,500 (derivative) @ $0 | EDGAR |
| 2024-08-16 | 4 | Vericel Corp (VCEL) | Option exercise (M): 17,500 @ $3.02 · Sale (S): 17,500 @ $45.17 · Option exercise (M): 17,500 @ $3.02 · Sale (S): 17,500 @ $46.24 · Option exercise (M): 17,500 (derivative) @ $0 · Option exercise (M): 17,500 (derivative) @ $0 | EDGAR |
| 2024-07-19 | 4 | Vericel Corp (VCEL) | Option exercise (M): 17,500 @ $3.02 · Sale (S): 17,500 @ $51.55 · Option exercise (M): 17,500 @ $3.02 · Sale (S): 17,500 @ $51.40 · Option exercise (M): 17,500 (derivative) @ $0 · Option exercise (M): 17,500 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Trevi Therapeutics, Inc. (TRVI) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Vericel Corp (VCEL) | Option exercise (M): 17,500 @ $3.02 · Sale (S): 17,500 @ $44.12 · Option exercise (M): 17,500 @ $3.02 · Sale (S): 17,500 @ $43.10 · Option exercise (M): 17,500 (derivative) @ $0 · Option exercise (M): 17,500 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | Vericel Corp (VCEL) | Option exercise (M): 17,500 @ $3.02 · Sale (S): 17,500 @ $49.67 · Option exercise (M): 17,500 @ $3.02 · Sale (S): 17,500 @ $47.85 · Option exercise (M): 17,500 (derivative) @ $0 · Option exercise (M): 17,500 (derivative) @ $0 | EDGAR |
| 2024-05-01 | 4 | Vericel Corp (VCEL) | Option exercise (M): 13,888 @ $7.20 · Option exercise (M): 6,002 @ $16.66 · Option exercise (M): 5,555 @ $18 · Option exercise (M): 13,888 (derivative) @ $0 · Option exercise (M): 6,002 (derivative) @ $0 · Option exercise (M): 5,555 (derivative) @ $0 | EDGAR |
| 2024-04-19 | 4 | Vericel Corp (VCEL) | Option exercise (M): 17,500 @ $3.02 · Sale (S): 17,500 @ $46.47 · Option exercise (M): 17,500 @ $3.02 · Sale (S): 17,500 @ $44.59 · Option exercise (M): 17,500 (derivative) @ $0 · Option exercise (M): 17,500 (derivative) @ $0 | EDGAR |
| 2024-03-15 | 4 | Vericel Corp (VCEL) | Option exercise (M): 17,500 @ $3.02 · Sale (S): 17,500 @ $44.67 · Option exercise (M): 17,500 @ $3.02 · Sale (S): 17,500 @ $44.02 · Option exercise (M): 17,500 (derivative) @ $0 · Option exercise (M): 17,500 (derivative) @ $0 | EDGAR |
| 2024-02-26 | 4 | Vericel Corp (VCEL) | Grant/award (A): 182,500 (derivative) @ $0 · Grant/award (A): 73,000 (derivative) @ $0 | EDGAR |
| 2024-02-22 | 4 | Vericel Corp (VCEL) | Option exercise (M): 18,250 @ $0 · Tax withholding (F): 8,459 @ $49.50 · Option exercise (M): 11,700 @ $0 · Tax withholding (F): 5,423 @ $49.50 · Option exercise (M): 8,937 @ $0 · Tax withholding (F): 4,143 @ $49.50 · +3 more | EDGAR |
| 2024-02-16 | 4 | Vericel Corp (VCEL) | Option exercise (M): 17,500 @ $3.02 · Sale (S): 17,500 @ $46.99 · Option exercise (M): 17,500 @ $3.02 · Sale (S): 17,500 @ $48.85 · Option exercise (M): 17,500 (derivative) @ $0 · Option exercise (M): 17,500 (derivative) @ $0 | EDGAR |
| 2024-02-13 | 4 | Vericel Corp (VCEL) | Option exercise (M): 7,500 @ $0 · Tax withholding (F): 3,477 @ $47.42 · Option exercise (M): 7,500 (derivative) | EDGAR |
| 2024-01-19 | 4 | Vericel Corp (VCEL) | Option exercise (M): 16,726 @ $3.02 · Sale (S): 16,726 @ $37.97 · Option exercise (M): 16,726 @ $3.02 · Sale (S): 16,726 @ $38.58 · Option exercise (M): 16,726 (derivative) @ $0 · Option exercise (M): 16,726 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1313403 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →